Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Veterinary Vaccine Market Size to Reach USD 13,681.4 Million in 2030| Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

04 Jan, 2023, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, B.C., Jan. 4, 2023 /PRNewswire/ -- The veterinary vaccine market size reached USD 7,975.3 Million in 2021 and is expected to register a CAGR of 6.2% during the forecast period, according to latest analysis by Emergen Research. Increasing adoption of pets, rising prevalence of zoonotic diseases, and surging cases of COVID-19 are some key factors driving veterinary vaccine market revenue growth.

Government organizations and animal associations are taking initiatives in investing in veterinary vaccines. Rising government initiatives and research activities are also increasing market growth. For instance, on 24 February 2022, the Government of Canada announced an investment to help to create more spaces for students in the University of Calgary Veterinary Medicine (UCVM) program in order to address the emergency shortage of veterinary professionals in the province.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/426

According to the report, it was stated that USD 59 million has been allocated to the provincial budget for 2022 to increase the Doctor of Veterinary Medicine (DVM) program. Additionally, over the last century, increasing adoption of pets, as well aa s variety of zoonotic disease outbreaks, have increased dramatically, which has led to a rise in demand for the veterinary vaccine. According to publicly available data from the American Society for the Prevention of Cruelty to Animals, 6.5 million dogs, cats, and other former pets are abandoned or lost each year and end up in shelters.

However, only 3.2 million of these animals are adopted, and many return to shelters after less than a year.  Human Society stated that approximately 85 million families own pets, with 28% of dogs and 31% of cats adopted from shelters each year. As a result, these factors are rising the demand for this market.

Drivers:

The number and variety of zoonotic disease outbreaks have increased dramatically over the last century, leading to an increase in global demand for veterinary vaccines. According to National Center for Biotechnology Information, zoonotic diseases account for 60% of all new infectious diseases in humans. In the US, millions of households have one or more pets. Animals may come into contact with human while traveling, visiting animal exhibits, engaging in outdoor activities, or in urban or rural settings. In the United States and throughout the world, zoonotic diseases are very prevalent.

According to the Centers for Disease Control and Prevention, 3 of each 4 new or emerging infectious diseases in humans and more than 6 out of every 10 known infectious diseases in humans can be transmitted from animals. As a result, the CDC works round-the-clock to safeguard people in both the United States and other countries from zoonotic diseases. As a result, prevalence of this diseases are driving the demand for veterinary vaccines and accelerating the market's revenue growth.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/veterinary-vaccines-market

Restraints:

There are some issues and difficulties facing the veterinary vaccine industry. One of the significant challenges hindering the growth of this industry is the side effects related to vaccination. There is always some risk involved with veterinary procedures and vaccinations. Vaccination protects cats and dogs from severe and common conditions and diseases. According to the report, for every 10,000 cats who receive a vaccination, 1-10 will suffer a serious side effect, and for every 10,000 dogs, 13 are predicted to experience a reaction.

the most frequent side effects that cats and dogs encounter, including lethargy, a slight fever, localized swelling, and cold and flu symptoms. The most serious allergic reaction that cats and dogs can experience after receiving vaccinations is anaphylaxis. Pets usually experience anaphylaxis very soon after receiving a vaccination. As a result, these side effects are hindering the growth of veterinary vaccine market.

Growth Projections:

The veterinary vaccine market is expected to register a CAGR of 6.2% over the forecast period and revenue is projected to increase from USD 7,975.3 Million in 2021 to USD 13,681.4 Million in 2030. Increasing spending in emerging markets is expected to support revenue growth of the market.

Current Trends and Innovations:

The veterinary vaccine industry is undergoing gradual changes during the forecast period. The development of live-attenuated and inactivated vaccines has improved food security, increased livestock productivity, and decreased the morbidity and mortality of numerous human, animal, and zoonotic diseases. The frequency of newly emerging infectious diseases keeps rising, necessitating the rapid introduction of new vaccines.

In the past three decades, veterinary medicine has taken the lead in developing novel vaccines to get around some of the drawbacks of conventional vaccines. These third-generation vaccines, which include recombinant viral-vector, DNA, and RNA vaccines, induce an immune response on the humoral and cellular levels, are produced affordably, are safe to use, and can be used to distinguish infected from vaccinated animals.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/426

Strategic Initiatives:

Major companies included in the market report are Indian Immunologicals Ltd., Merck & Co., Inc., Ceva., Zoetis, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Phibro Animal Health Corporation., Neogen Corporation., Brilliant Bio Pharma, Elanco.

  • On 10 March 2021, Zoetis Inc. announced its long-term sustainability goals, which enlarge the company's mission to nurture the world and humankind by advancing animal care. Zoetis draws its specific commitments to Communities, Animals, and the Planet under the banner Driven to Care, including support for 10 of the 17 United Nations Sustainable Development Goals (SDGs). Zoetis has the global reach and skills to support a healthier, more sustainable future for all, with operations in 45 countries.

Scope of Research

Report Details

Outcome

Market Size in 2021

USD 7,975.3 Million

CAGR (2022–2030)

6.2 %

Revenue Forecast to 2030

USD 13,681.4 Million

Base Year for Estimation

2021

Historical Data

2019–2020

Forecast Period

2022–2030

Quantitative Units

Revenue in USD Million and CAGR in % from 2022 to 2030

Report Coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments Covered

Disease type, animal type, administration route, technology, and region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Country Scope

U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa

Key Companies Profiled

Indian Immunologicals Ltd., Merck & Co., Inc., Ceva., Zoetis, Eli Lilly and Company, Boehringer Ingelheim International GmbH.,

Phibro Animal Health Corporation., Neogen Corporation., Brilliant Bio Pharma, and Elanco

Customization Scope

10 hours of free customization and expert consultation

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/426

Emergen Research has segmented veterinary vaccine market on the basis of disease type, animal type, administration route, technology, and region:

  • Disease Type Outlook (Revenue, USD Million; 2019-2030)
    • Avian Influenza
    • Rabies coccidiosis
    • Brucellosis
    • Canine distemper
    • Swine pneumonia
  • Animal Type Outlook (Revenue, USD Million; 2019-2030)
    • Livestock
      • Poultry
      • Cattle
      • Others (horses, goat, camel and others).
    • Companion
      • Cats
      • Dogs
    • Aquacultures
    • Others
  • Administration Route Outlook (Revenue, USD Million; 2019-2030)
    • Oral
    • Injection
    • Spray
  • Technology Outlook (Revenue, USD Million; 2019-2030)
    • Live attenuated vaccine
    • Inactivated vaccine
    • Recombinant
  • Regional Outlook (Revenue, USD Million, 2019 - 2030)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Australia
      • Rest of APAC
    • Latin America
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • Africa
      • Rest of Middle East

Latest Research Reports Published by Emergen Research:

Security Robot Market, By Type (Ground Robots, Aerial Robots, Underwater), By Application (Spying and Firefighting), By Components (Hardware, Software, and Services), By End-Use (Defense & Military, Residential), and By Region Forecast to 2030

Pushbutton Industrial Wireless Remote Control Market By Type (Handheld and Stationary), By Application (Industry & Logistics, Construction Crane, Mobile Hydraulics, Forestry, and Mining), and By Region Forecast to 2030

LEO Satellite Market, By Subsystem, By Type, By Application (Imaging & Earth Observations, Satellite Communications, Science & Explorations, and Others), By End-Use, and By Region Forecast to 2030

Geofoam Market By Type (Expanded Polystyrene Geofoam and Extruded Polystyrene Geofoam), By End-Use (Road & Highway Construction, Building & Infrastructure, Airport Runway & Taxiways), By Application, and By Region Forecast to 2030

Electronic Cash Register Market, By Type, By Product (Standard Electronic Cash Register, Computerized Port System, Mobile Port System, and Cloud-Based Cash Registers), By End-Use, By Region Forecast to 2030

DJ Equipment Market, By Component, By Application (Individual Amateurs and Professional Performance), By Distribution Channel, By End-Use, and By Region Forecast to 2030

Colonoscopy Market, By Product Type, By Application (Colorectal Cancer Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyps or Colorectal Cancer, Others), By End-Use, and By Region Forecast to 2030

Bone Growth Stimulator Market, By Product, By Application (Spinal Fusion Surgeries, Delayed Union & Non-Union Bone Fractures, Oral & Maxillofacial Surgeries, and Others), By End-Use, and By Region Forecast to 2030

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com 
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release @ https://www.emergenresearch.com/press-release/global-veterinary-vaccines-market
Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.